These factors could be potential reasons behind the different results obtained from each of these studies, especially the one by Bi and colleagues which is the only study that shows an oncogenic potential for ARID1A. The above data suggested that ARID1A variations regardless of low or high expression was correlated with the prognostic significance in CCA. This evidence concerns the gene ARID1A and cholangiocarcinoma.